[1] |
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria[J]. Allergy, 2018,73(7):1393⁃1414. doi: 10.1111/all.13397.
|
[2] |
Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update[J]. J Allergy Clin Immunol, 2014,133(5):1270⁃1277. doi: 10.1016/j.jaci.2014.02.036.
|
[3] |
中华医学会皮肤性病学分会免疫学组. 中国荨麻疹诊疗指南(2014版)[J]. 中华皮肤科杂志, 2014,47(7):514⁃516. doi: 10. 3760/cma.j.issn.0412⁃4030.2014.07.019.
|
[4] |
朱奕锜, 唐慧, 王朵勤, 等. 维生素D与慢性荨麻疹的研究进展[J]. 国际皮肤性病学杂志, 2017,43(4):223⁃226. doi: 10. 3760/cma.j.issn.1673⁃4173.2017.04.010.
|
[5] |
Song Z, Zhai Z, Zhong H, et al. Evaluation of autologous serum skin test and skin prick test reactivity to house dust mite in patients with chronic spontaneous urticaria[J/OL]. Plos One, 2013,8(5):e64142[2018⁃03⁃24]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669345/. doi: 10.1371/journal.pone.0064142.
|
[6] |
Pałgan K, Bartuzi Z. Platelet activating factor in allergies[J]. Int J Immunopathol Pharmacol, 2015,28(4):584⁃589. doi: 10.1177/0394 632015600598.
|
[7] |
Wang D, Tang H, Shen Y, et al. Activation of the blood coagulation system in patients with chronic spontaneous urticaria[J]. Clin Lab, 2015,61(9):1283⁃1288.
|
[8] |
赵作涛, 郝飞. 中国荨麻疹诊疗指南(2014版)解读[J]. 中华皮肤科杂志, 2016,49(6):388⁃390. doi: 10.3760/cma.j.issn.0412⁃4030.2016.06.005.
|
[9] |
Beck LA, Bernstein JA, Maurer M. A review of international recommendations for the diagnosis and management of chronic urticaria[J]. Acta Derm Venereol, 2017,97(2):149⁃158. doi: 10. 2340/00015555⁃2496.
|
[10] |
Weller K, Groffik A, Church MK, et al. Development and vali⁃dation of the urticaria control test: a patient⁃reported outcome instrument for assessing urticaria control[J]. J Allergy Clin Immunol, 2014,133(5):1365⁃1372,1372.e1⁃6. doi: 10.1016/j.jaci. 2013.12.1076.
|
[11] |
Zhong H, Song Z, Chen W, et al. Chronic urticaria in Chinese population: a hospital⁃based multicenter epidemiological study [J]. Allergy, 2014,69(3):359⁃364. doi: 10.1111/all.12338.
|
[12] |
Fine LM, Bernstein JA. Guideline of chronic urticaria beyond[J]. Allergy Asthma Immunol Res, 2016,8(5):396⁃403. doi: 10. 4168/aair.2016.8.5.396.
|
[13] |
温雯婷, 黄晶晶, 王鹏丽, 等. 雷公藤多苷片联合抗组胺药治疗慢性荨麻疹系统评价[J]. 中国中医药信息杂志, 2016,23(10):46⁃50. doi: 10.3969/j.issn.1005⁃5304.2016.10.012.
|
[14] |
Zhao ZT, Ji CM, Yu WJ, et al. Omalizumab for the treatment of chronic spontaneous urticaria: a meta⁃analysis of randomized clinical trials[J]. J Allergy Clin Immunol, 2016,137(6):1742⁃1750.e4. doi: 10.1016/j.jaci.2015.12.1342.
|
[15] |
Staubach P, Metz M, Chapman⁃Rothe N, et al. Effect of omalizumab on angioedema in H1⁃antihistamine⁃resistant chronic spontaneous urticaria patients: results from X⁃ACT, a randomized controlled trial[J]. Allergy, 2016,71(8):1135⁃1144. doi: 10.1111/all.12870.
|
[16] |
Sabroe RA. Commentary: omalizumab for the treatment of chronic idiopathic or spontaneous urticaria[J]. Br J Dermatol, 2014,171(1):13⁃15. doi: 10.1111/bjd.13074.
|
[17] |
Bishnoi A, Parsad D, Vinay K, et al. Phototherapy using narrow⁃band ultraviolet B and psoralen plus ultraviolet A is beneficial in steroid⁃dependent antihistamine⁃refractory chronic urticaria: a randomized, prospective observer⁃blinded comparative study[J]. Br J Dermatol, 2017,176(1):62⁃70. doi: 10.1111/bjd.14778.
|
[18] |
赵作涛. 诱导性荨麻疹治疗的选择[J]. 皮肤病与性病, 2015,37(1):19. doi: 10.3969/j.issn.1002⁃1310.2015.01.012.
|
[19] |
Maurer M, Church MK, Gonçalo M, et al. Management and treatment of chronic urticaria (CU)[J]. J Eur Acad Dermatol Venereol, 2015,29 Suppl 3:16⁃32. doi: 10.1111/jdv.13198.
|
[20] |
温禾, 姚煦. 抗组胺药在特殊人群中的应用[J]. 中华皮肤科杂志, 2016,49(9):669⁃671. doi: 10.3760/cma.j.issn.0412⁃4030. 2016.09.022.
|
[21] |
Namazy J, Cabana MD, Scheuerle AE, et al. The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy [J]. J Allergy Clin Immunol, 2015,135(2):407⁃412. doi: 10.1016/j.jaci.2014.08.025.
|